dalfampridine April 12, 2017 dalfampridine Trade Name Ampyra Orphan Indication Relief of symptoms of multiple sclerosis USA Market Approval USA USA Designation Date 1987-06-02 00:00:00 Sponsor Acorda Therapeutics;15 Skyline Dr.;Hawthorne, New York, 10532
